Taylor HS

No ORCID on file · 4 papers in corpus · active 2018-2026

Study types

  • article 2
  • dataset 2

Condition tags

  • endometriosis 4
  • dysmenorrhea 3
  • dyspareunia 1
dataset 2026
Supplementary Material for: Association between body mass index and dysmenorrhea in women with endometriosis: a systematic review and meta-analysis
·doi:10.6084/m9.figshare.31407042

Background: Dysmenorrhea is a debilitating symptom in patients with endometriosis, contributing significantly to disease burden. While the relationship between body mass index (BMI) and dysmenorrhea in these patients is unclear, emerging ev…

dataset 2026
Supplementary Material for: Association between body mass index and dysmenorrhea in women with endometriosis: a systematic review and meta-analysis
·doi:10.6084/m9.figshare.31407042.v1

Background: Dysmenorrhea is a debilitating symptom in patients with endometriosis, contributing significantly to disease burden. While the relationship between body mass index (BMI) and dysmenorrhea in these patients is unclear, emerging ev…

article 2020
Real-World Characterization of Women with Diagnosed Endometriosis Initiating Therapy with Elagolix Using a US Claims Database

Eric S Surrey,1 Ahmed M Soliman,2 Beverly Johns,2 Jamie B Vora,3 Hugh S Taylor,4 Sanjay K Agarwal5 1Colorado Center for Reproductive Medicine, Lone Tree, CO, USA; 2Health Economics and Outcomes Research, AbbVie Inc, North Chicago, IL, USA; …

article 2018
Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist
·doi:10.1530/ey.15.15.6

We highlight this paper for 3 reasons. First, remarkably there are few robust data on effective treatment options for endometriosis. Subcutaneous GnRH antagonists are sometimes used off-label, but with very limited evidence. Secondly, the c…